Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients.

Lorenzo BertaniDomenico TricòDaniela PuglieseGiuseppe PriviteraGiuseppe LinsalataFederico ZanziMaria Gloria MumoloBrigida BarberioFabio MonzaniSantino MarchiLuisa GuidiCorrado BlandizziAlessandro ArmuzziFrancesco Costa

Published in: Alimentary pharmacology & therapeutics (2020)

T3/T4 ratio seems a reliable tool for predicting therapeutic outcome of biological therapy in elderly patients with IBD. If validated, the assessment of this parameter before starting biological treatment might be suggested.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
middle aged
chronic kidney disease
peritoneal dialysis
prognostic factors
stem cells
patient reported outcomes